CARGO Therapeutics Inc. C... (CRGX)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -98.15M -40.95M -5.85M
Depreciation & Amortization 3.69M 1.44M 147.00K
Stock-Based Compensation 3.33M 297.00K 507.00K
Other Working Capital 1.45M 148.00K -78.00K
Other Non-Cash Items 7.75M 5.96M 469.00K
Deferred Income Tax - 1.22M -
Change in Working Capital 2.21M 2.97M 254.00K
Operating Cash Flow -81.16M -29.07M -4.94M
Capital Expenditures -8.99M -3.28M -442.00K
Acquisitions - - -
Purchase of Investments - - -
Sales Maturities Of Investments - - -
Other Investing Acitivies -715.00K -558.00K -
Investing Cash Flow -8.99M -3.28M -442.00K
Debt Repayment 3.50M 28.45M -
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 194.48M 5.73M 5.41M
Financial Cash Flow 494.58M 34.19M 5.41M
Net Cash Flow 404.43M 1.83M 30.00K
Free Cash Flow -90.16M -32.35M -5.38M